高级检索
当前位置: 首页 > 详情页

The role and therapeutic potential of nuclear factor cB (NF-cB) in ischemic stroke

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]Hebei Med Univ, Hosp 3, Dept Rehabil Med, Shijiazhuang 050051, Peoples R China [2]Hebei Med Univ, Hosp 3, Dept Clin Lab Med, Shijiazhuang 050051, Peoples R China [3]Hebei Univ, Affiliated Hosp, Dept Radiotherapy, Baoding 071000, Peoples R China [4]Hebei Med Univ, Coll Basic Med, Shijiazhuang 050017, Peoples R China [5]Collaborat Innovat Ctr Forens Med Mol Identificat, Hebei Key Lab Forens Med, Shijiazhuang 050017, Peoples R China [6]Chinese Acad Med Sci, Res Unit Digest Tract Microecosystem Pharmacol & T, Shijiazhuang 050017, Peoples R China [7]Hebei Med Univ, Dept Physiol, 361 East Zhongshan Rd, Shijiazhuang 050017, Peoples R China [8]Hebei Med Univ, Hosp 3, Dept Rehabil Med, 139 Ziqiang Rd, Shijiazhuang 050051, Hebei, Peoples R China
出处:
ISSN:

关键词: Nuclear factor cB Ischemic stroke Neuroinflammation Blood-brain-barrier

摘要:
Stroke is a prevalent cerebrovascular condition with a global impact, causing significant rates of illness and death. Despite extensive research, the available treatment options for stroke remain restricted. Hence, it is crucial to gain a deeper understanding of the molecular mechanisms associated with the onset and advancement of stroke in order to establish a theoretical foundation for novel preventive and therapeutic approaches. NF-cB, also known as nuclear factor cB, is a transcription factor responsible for controlling the expression of numerous genes and plays a crucial role in diverse physiological processes. NF-cB is triggered and regulates neuroinflammation and other processes after stroke, promoting the generation of cytokine storms and contributing to the advancement of ischemic stroke (IS). Therefore, NF-cB could potentially play a vital role in stroke by regulating diverse pathophysiological processes. This review provides an overview of the functions of NF-cB in stroke and its governing mechanisms. In addition, our attention is directed towards various potential therapies that aim to inhibit the NF-cB signaling pathway in order to offer valuable insights for the advancement of innovative treatment approaches for stroke.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2025]版:
最新[2025]版:
大类 | 2 区 医学
小类 | 2 区 医学:研究与实验 2 区 药学
JCR分区:
出版当年[2024]版:
最新[2023]版:
Q1 MEDICINE, RESEARCH & EXPERIMENTAL Q1 PHARMACOLOGY & PHARMACY

影响因子: 最新[2023版] 最新五年平均 出版当年[2024版] 出版当年五年平均 出版前一年[2023版]

第一作者:
第一作者机构: [1]Hebei Med Univ, Hosp 3, Dept Rehabil Med, Shijiazhuang 050051, Peoples R China
共同第一作者:
通讯作者:
通讯机构: [1]Hebei Med Univ, Hosp 3, Dept Rehabil Med, Shijiazhuang 050051, Peoples R China [4]Hebei Med Univ, Coll Basic Med, Shijiazhuang 050017, Peoples R China [5]Collaborat Innovat Ctr Forens Med Mol Identificat, Hebei Key Lab Forens Med, Shijiazhuang 050017, Peoples R China [6]Chinese Acad Med Sci, Res Unit Digest Tract Microecosystem Pharmacol & T, Shijiazhuang 050017, Peoples R China [7]Hebei Med Univ, Dept Physiol, 361 East Zhongshan Rd, Shijiazhuang 050017, Peoples R China [8]Hebei Med Univ, Hosp 3, Dept Rehabil Med, 139 Ziqiang Rd, Shijiazhuang 050051, Hebei, Peoples R China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:15709 今日访问量:3 总访问量:1038 更新日期:2025-06-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 河北大学附属医院 技术支持:重庆聚合科技有限公司 地址:保定市莲池区裕华东路212号